Subscribe To
AnaptysBio Announces Participation in Upcoming Investor Conferences
SAN DIEGO, May 30, 2023 (GLOBE NEWSWIRE) — AnaptysBio, Inc. (Nasdaq: ANAB), a clinical-stage biotechnology company focused on delivering innovative immunology therapeutics, today announced that Daniel Faga, interim president and chief executive officer of AnaptysBio, and other members of its senior management team are scheduled to participate in both of the upcoming investor conferences below: […] The post AnaptysBio Announces Participation in Upcoming Investor Conferences appeared first on Fore...
Read More
Posted: May 30 2023, 20:15
Author Name: forextv
Views: 111664